Search

everythinglearnresearchcommunity

for

Search:↓

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

A rare ovarian tumor that produced testosterone caused a blood clot in the lungs and increased red blood cells in a woman.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Meis1 is crucial for skin health and tumor development.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The document concludes that more research is needed to fully understand the causes of PCOS.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

Ultrasound-based radiomics and radiogenomics can improve ovarian cancer diagnosis and treatment, but need better standardization and AI tools.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Early life factors, including a mother's health and environment, can affect the chances of developing polycystic ovary syndrome later in life.

A rare benign ovarian tumor was found in a pregnant woman, but both mother and baby remained healthy.

Accurate diagnosis of rare hyperandrogenism conditions requires detailed testing and sometimes invasive procedures.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

A rare ovarian tumor was diagnosed in a woman from North Brazil, and surgery is the preferred treatment.

A woman's excessive hair growth and high testosterone were caused by a rare ovarian tumor, which was successfully treated with surgery.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.